TABLE 1.

Patient Demographics (n = 24)

Age (years; mean ± SD)56 ± 8
Male (n [%])16 (67)
Race/ethnicity (n [%])
 Hispanic/Latino14 (58)
 White9 (38)
 African American1 (4)
Transplanted organ (n [%])
 Kidney10 (42)
 Liver8 (33)
 Lung5 (21)
 Lung/kidney1 (4)
Mean time since transplant (months)52
Transplant immunosuppression (n [%])
 Tacrolimus23 (96)
 Cyclosporine1 (4)
 Prednisone17 (71)
  >5 mg daily4 (17)
  5 mg daily12 (50)
  <5 mg daily1 (4)
Diabetes pharmacotherapy (n [%])
 Insulin19 (79)
  Long-acting (basal)2 (8)
  Short-acting (bolus)3 (13)
  Basal plus bolus14 (58)
 Metformin1 (4)
 Thiazolidinedione1 (4)
 None4 (17)
Nonadherence* (n [%])7 (29)
Diabetes diagnosis pre-transplant (n [%])7 (29)
Hepatitis C virus infection (n [%])
 Active infection6 (25)
 History of infection2 (8)
BMI (n = 23) (kg/m2, mean ± SD)27.33 ± 4.28
A1C (n = 20) (% [IQR])8.05 (6.33–11.75)
7-day SMBG result (n = 20) (mg/dL, mean [IQR])191 (138–232)
Fasting SMBG result (n = 19) (mg/dL, mean [IQR])153 (117–208)
Pre-lunch SMBG result (n = 12) (mg/dL, mean [IQR])212 (159–258)
  • * At least one self-reported missed dose of an antidiabetes medication in the past 7 days.